Teladoc Health (NYSE: TDOC) Q1 2026 revenue dips as loss narrows

Teladoc Health reported a 2% year-over-year revenue decrease to $613.8 million in Q1 2026, while its net loss narrowed significantly from $93.0 million to $63.8 million, primarily due to the absence of a prior goodwill impairment charge. The company reaffirmed its full-year 2026 financial outlook, anticipating revenue between $2.48 billion and $2.58 billion and positive free cash flow. Integrated Care segment revenue grew, but BetterHelp revenue declined, reflecting mixed performance across its services.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin